Biopharmaceuticals
Cardiology
Product Launch
News Release - June 12, 2017
Cardiome Announces Commercial Launch of BRINAVESS(R) (Vernakalant Hydrochloride) in Canada
Source: Cardiome Pharma
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.